Evidence Hub

RETRACTED ARTICLE: The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial

L. Nazari, S. Salehpour, M. Hosseini, Parisa Hashemi Moghanjoughi

Human Fertility, 2019

86 citations

Abstract

We, the Editor and Publisher of Human Fertility, have retracted the following article: Nazari, L., Salehpour, S., Hosseini, M. S., & Hashemi Moghanjoughi, P. (2020). The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial. Human Fertility, 23(3), 209–213. https://doi.org/10.1080/14647273.2019.1569268 Following publication, significant concerns have been raised regarding the integrity of the data and reported results in the article. When approached for an explanation, the authors responded to these concerns and provided raw data for verification, but these have not sufficiently addressed the concerns raised. As we cannot confirm the validity of the results as reported, we are therefore retracting the article. The authors have been informed of this decision. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free